TransMedics Group, Inc. — Director's Dealing 2022

Nov 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2022-11-22

Reporting Person: Lovell Stephanie (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-22	Common Stock	M	3800	$47.82	Acquired	3800	Direct
2022-11-22	Common Stock	S	3800	$57.97	Disposed	0	Direct
2022-11-22	Common Stock	M	1100	$26.26	Acquired	1100	Direct
2022-11-22	Common Stock	S	1100	$58.04	Disposed	0	Direct
2022-11-23	Common Stock	M	5657	$47.82	Acquired	5657	Direct
2022-11-23	Common Stock	S	5657	$59.50	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-22	Stock Option (Right to Buy)	$47.82	M	3800	Disposed	2031-03-22	Common Stock (3800)	Direct
2022-11-22	Stock Option (Right to Buy)	$26.26	M	1100	Disposed	2031-05-27	Common Stock (1100)	Direct
2022-11-23	Stock Option (Right to Buy)	$47.82	M	5657	Disposed	2031-03-22	Common Stock (5657)	Direct

Footnotes

F1: The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.